Manuela G. Lopez-Garcia - Publications

Corrigendum to "Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment" [Biomed. Pharmacother. 183 (2025) 117829].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 02, 2026

Dynamics of Xpert MTB/RIF Ultra results in follow-up sputum samples during the first month of TB treatment.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: February 10, 2026

Alkaloids from In Vitro Cultured Rhodophiala pratensis Display Neuroprotective Effects in Murine Microglial Cell Models of Inflammation.

Journal: Plants (Basel, Switzerland)

Published: January 14, 2026

Timing of microglial ablation determines protection from tau-mediated neurodegeneration and cognitive decline.

Journal: Acta neuropathologica communications

Published: October 06, 2025

Long-term NRF2-driven microglial repopulation mitigates microgliosis, neuronal loss and cognitive deficits in tauopathy.

Journal: Brain, behavior, and immunity

Published: June 11, 2025

Corrigendum to "Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases" [Redox Biol. 79 (2025) 103464].

Journal: Redox biology

Published: January 20, 2025

Health position paper and redox perspectives - Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases.

Journal: Redox biology

Published: December 21, 2024

Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases.

Journal: Redox biology

Published: October 25, 2024

Targeting CB2 receptor with a novel antagonist reverses cognitive decline, neurodegeneration and pyroptosis in a TAU-dependent frontotemporal dementia mouse model.

Journal: Brain, behavior, and immunity

Published: September 23, 2024

Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 25, 2024

The mitochondrial Na+/Ca2+ exchanger NCLX is implied in the activation of hypoxia-inducible factors.

Journal: Redox biology

Published: July 15, 2024

Discovery of a potent melatonin-based inhibitor of quinone reductase-2 with neuroprotective and neurogenic properties.

Journal: European journal of medicinal chemistry

Published: June 12, 2024